P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY
Κύριοι συγγραφείς: | Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Wiley
2023-08-01
|
Σειρά: | HemaSphere |
Διαθέσιμο Online: | http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2 |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
ανά: Sikander Ailawadhi, κ.ά.
Έκδοση: (2024-11-01) -
Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
ανά: Hans C. Lee, κ.ά.
Έκδοση: (2021-07-01) -
Connect MM Registry as a national reference for United States multiple myeloma patients
ανά: Sikander Ailawadhi, κ.ά.
Έκδοση: (2020-01-01) -
Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
ανά: Sundar Jagannath, κ.ά.
Έκδοση: (2018-07-01) -
Lenalidomide-Associated ITP
ανά: Christina I. Herold, κ.ά.
Έκδοση: (2011-01-01)